Mammography screening reduces rates of advanced and fatal breast cancers : Results in 549,091 women

Autor: Laszlo Tabar, Hans Wallin, Per Sundén, Sven Törnberg, Tony Hsiu Hsi Chen, Helene Grundström, Joakim Ramos, Sherry Yueh Hsia Chiu, Lars Holmberg, Johan Ahlgren, Karin Leifland, Stephen W. Duffy, Anders Åkerlund, Håkan Jonsson, Ann Sundbom, Birgitta Epstein, Chen Yang Hsu, Yu Ching Chen, Edward Azavedo, Ewa Frodis, Leena Starck, Pál Bordás, Irma Fredriksson, Wendy Yi Ying Wu, May Mei Sheng Ku, Annika Björkgren, Stina Carlson, Peter B. Dean, Daniel Öhman, Jean Ching Yuan Fann, Amy Ming Fang Yen, Robert A. Smith, Gunilla Svane, Sam Li Sheng Chen
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Cancer
Popis: Background It is of paramount importance to evaluate the impact of participation in organized mammography service screening independently from changes in breast cancer treatment. This can be done by measuring the incidence of fatal breast cancer, which is based on the date of diagnosis and not on the date of death. Methods Among 549,091 women, covering approximately 30% of the Swedish screening‐eligible population, the authors calculated the incidence rates of 2473 breast cancers that were fatal within 10 years after diagnosis and the incidence rates of 9737 advanced breast cancers. Data regarding each breast cancer diagnosis and the cause and date of death of each breast cancer case were gathered from national Swedish registries. Tumor characteristics were collected from regional cancer centers. Aggregated data concerning invitation and participation were provided by Sectra Medical Systems AB. Incidence rates were analyzed using Poisson regression. Results Women who participated in mammography screening had a statistically significant 41% reduction in their risk of dying of breast cancer within 10 years (relative risk, 0.59; 95% CI, 0.51‐0.68 [P
Substantial and significant reductions in the incidence rates of fatal breast cancer and advanced breast cancer with 10 years of follow‐up are observed in this analysis of greater than one‐half million Swedish women participating and not participating in breast cancer screening. These comparisons are contemporaneous, and thus are not influenced by changes in therapeutic regimens.
Databáze: OpenAIRE